XOMA Royalty (XOMA) Free Cash Flow (QoQ) (2010 - 2026)
XOMA Royalty (XOMA) Free Cash Flow (QoQ) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | XOMA Royalty | 478.42 Mn | 412.34 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 211.27% |
| Jun 30, 2025 | 194.36% |
| Mar 31, 2025 | 175.64% |
| Dec 31, 2024 | 66.31% |
| Sep 30, 2024 | -416.28% |
| Jun 30, 2024 | 154.94% |
| Mar 31, 2024 | -26.41% |
| Dec 31, 2023 | -87.09% |
| Sep 30, 2023 | 70.88% |
| Jun 30, 2023 | -46.39% |
| Mar 31, 2023 | -26.58% |
| Dec 31, 2022 | -6.20% |
| Sep 30, 2022 | 15.15% |
| Jun 30, 2022 | -327.85% |
| Mar 31, 2022 | -103.29% |
| Dec 31, 2021 | 1,096.49% |
| Sep 30, 2021 | 22.64% |
| Jun 30, 2021 | -334.90% |
| Mar 31, 2021 | -105.17% |
| Dec 31, 2020 | 825.70% |